Disclosures for "Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States"
-
Dr. Mallick has received personal compensation for serving as an employee of CSL Behring.
-
Alphonse Hubsch has received personal compensation for serving as an employee of CSL Behring. Alphonse Hubsch has stock in CSL Behring .
-
Mr. Carlton has received personal compensation for serving as an employee of Cencora. Mr. Carlton has stock in Cencora.
-
Mr. van Stiphout has nothing to disclose.
-
Ms. Lahue has received personal compensation for serving as an employee of Alkemi . An immediate family member of Ms. Lahue has received personal compensation for serving as an employee of Alkemi. Ms. Lahue has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for EvoEndo. An immediate family member of Ms. Lahue has stock in Pfizer.